Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Germany Pharmaceutical Pricing & Reimbursement Guide 2016 - Research and Markets

Research and Markets
Posted on: 04 Oct 16

Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Germany" report to their offering.

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered:

1. HEALTHCARE SYSTEM

Facts & Figures

Market Indicators

Provision & Funding

Statutory Health Insurance

Private Health Insurance

Healthcare Services

Healthcare Reform

2. PRICING

Prescription Drugs

Early Benefit Assessments

Rebate Negotiations Following Early Benefit Assessments

Market Developments

Mandatory Rebates

Voluntary Discount Agreements

Generic Drugs

Mandatory Discounts

Voluntary Discount Agreements

Hospital Drugs

Pricing

Purchasing

Dispensing to Out-patients

OTC Drugs

Discounts

3. REIMBURSEMENT

Admission to Reimbursement

Non-prescription Drugs

Lifestyle Drugs

Minor Illnesses

Unproven Therapeutic Benefit, Medical Necessity or Economic Efficiency

Therapeutic Recommendations

Off-label Drugs

Negative List

Reimbursement Categories

Reimbursement Prices

Reference Price System

Hospital Reimbursement

Formularies

Funding

4. PHARMACOECONOMICS

Pharmacoeconomic Requirements

Early Benefit Assessments

Benefit Assessments

Cost-benefit Assessments

5. PRICE BUILD UP

Wholesalers

Margins

Discounts

Direct Distribution

Unit-dose Products

Background

Retail Pharmacies

Prescription Drugs

Non-Prescription Drugs

Parallel Import Quota

Background

Dispensing Doctors

Sales Tax

6. COST CONTAINMENT

Industry Paybacks

Promotional Costs

Advertising

Payments to Physicians

Patient Co-payments

GKV

PKV

Prescribing Controls

Binding Prescribing Guidelines

Prescribing Conditions for Drugs Subject to Early Benefit Assessments

Regional Prescribing Agreements

Disease Management Programmes

7. FUTURE DEVELOPMENTS

Outlook

Germany, Pharmaceutical Pricing & Reimbursement Concise Guide

Biosimilars Savings Potential

Parallel Import Dispensing Quota Controversy

8. NAMES & ADDRESSES

For more information about this report visit http://www.researchandmarkets.com/research/kp6m9s/ims

View source version on businesswire.com: http://www.businesswire.com/news/home/20161004005748/en/

Business Wire
www.businesswire.com

Last updated on: 04/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.